On February 6, the three major A-share indices collectively surged, and the GEM index led the rise. By the close, the Shanghai index was up 3.23%, the Shenzhen index was up 6.22%, and the GEM index was up 6.71%. More than 3,800 individual stocks rose in the entire market. The turnover of the Shanghai and Shenzhen markets was 926.3 billion yuan, and Northbound Capital made a net purchase of 12.605 billion dollars throughout the day.

A total of 144 shares rose or closed today. The total number of shares on the board was 7, and 88 shares failed to be sealed. The sealing rate was 62% (excluding ST shares, delisted shares, and unopened IPOs).

In terms of individual stocks, the state-owned enterprise reform sector Zhongji Health 5 board, Shengguang Group 3 day 2 board, power investment and financing 4 day 2 board, new quality productivity concept stock Kelai Mechatronics 4 board, Saimo Smart GEM 2 board, Beijing Stock Exchange's concentric transmission 30CM3 board, optical communication concept stock Changjiang Communications 2 board, Guangku Technology Venture Board first board, and pharmaceutical stock Ed Biotech Venture Board first board.

Let's take a look at today's Dragon Tiger rankings:

The top three net purchases on the Dragon Tiger list today were Guangku Technology, Longjin Pharmaceutical, and Nanxinwei, which were 86.8312 million yuan, 52.8949 million yuan, and 49.5526 million yuan respectively.

The top three net sales in the Dragon Tiger list were Ed Biotech, Hasson Co., Ltd., and Inner Mongolia Xinhua, which were 97.7578 million yuan, 48.1095 million yuan, and 387.375 million yuan respectively.

Among the individual stocks involved in exclusive institutional seats in the Dragon Tiger list, the top three were Nanochip, Rongchang Biotech, and Haier Biotech for the same day, which were 66.5077 million yuan, 25.3965 million yuan, and 145.744 million yuan respectively.

Among the individual stocks involved in exclusive institutional seats in the Dragon Tiger list, the top three were Shenzhen Huafa A, Qingdao Food, and Yidao Information, which were 19.5209 million yuan, 16.6595 million yuan, and 13.8016 million yuan respectively.

The subject of some of the individual stocks on the list:

Optical library technology(Zhuhai+upstream optical module/lithium niobate chip+lidar)

1. The company is a state-owned enterprise. The final controller is the State-owned Assets Supervision and Administration Committee of the Zhuhai Municipal People's Government. Its main business is a high-tech enterprise with the design, R&D, production, sales and service of optical fiber devices.
2. Company interaction on March 17, 23: The company showcased various products such as lithium niobate modulators, lidar light source modules, optical network passive devices and microconnections at the 2023 US Optical Fiber Communications Expo. Microconnection products include 90° bent optical fiber arrays, 400G DR4 components, multi-channel fiber arrays, polarization-maintaining fiber arrays, etc., which are mainly used in high-speed and ultra-high-speed optical modules such as 400G/800G/1.6T.

Longjin Pharmaceutical(Traditional Chinese Medicine+Innovative Medicine+Industrial Cannabis)

1. The company is mainly engaged in R&D, production and sales of modern traditional Chinese medicine and specialty chemical generic drugs.
2. In response to investors' questions, the company stated that according to the “Proprietary Chinese Medicine Provincial Alliance Centralized Volume Procurement Results Announcement” issued by the Proprietary Chinese Medicine Provincial Alliance Collecting Leading Group Office on December 21, 2021, the company's injectable product, Dengzhanhuacin, is intended to be selected for centralized volume procurement by the Interprovincial Alliance. The proposed procurement period is two years (the procurement agreement is signed once a year), and the scope of supply after winning the bid is covered by the Interprovincial Alliance. However, with the gradual and full implementation of centralized procurement of proprietary Chinese medicines, non-harvesting provinces have begun implementing a collection price linkage policy.

Abbison(Annual report pre-increase+LED)

1. According to institutional research on January 31, 2024, the company is a pioneer in the industry to lay out inverted COB technology. With the commissioning and operation of the COB Phase II mass production workshop, Abbison's competitiveness in the high-end micro-pitch display market has greatly improved.
2. The company is the world's leading true LED display application and service provider, providing customers with a full range of LED large-screen display products and professional audiovisual solutions. The company launched a variety of mini LED products, including AX series, HC series, CR series, A27Pro series, etc. The company's display products can be used in XR virtual shooting scenes.
3. The LED display categories provided by the company range from outdoor to indoor, and the company's products are widely used in various scenarios such as advertising displays and stage displays. The company has implemented a number of naked eye 3D benchmark projects around the world, including Guangzhou Baiyun Kaishaoye City Plaza.

Institutions focus on trading individual stocks:

Nanochip: Today's increase was 19.39%, with a turnover rate of 3.11%, and a turnover of 283 million yuan, an increase of 22.11%. According to Dragon Tiger List data, 3 institutions bought 76.8985 million yuan, and 1 agency sold 10.398 million yuan.

Rongchang Biotech: It went up and down today, with a turnover rate of 2.87% and a turnover of 175 million yuan, an amplification of 23.98%. According to Dragon Tiger List data, 3 institutions bought 34.227 million yuan, and 1 agency sold 8.830,500 yuan.

Haier Biotech: Today's increase was 18.57%, the turnover rate was 1.44%, and the turnover was 132 million yuan, an increase of 22.32%. According to Dragon Tiger List data, 2 institutions bought 17.937,500 yuan, and 1 agency sold 3.3631 million yuan.

Miao Exhibition: Today's increase was 13.81%, with a turnover rate of 2.62%, a turnover of 75.2715 million yuan, an amplification of 30.87%. According to data from the Dragon Tiger Index, the net sale of exclusive seats on Shenzhen Stock Connect was 4.6095 million yuan, and the net purchase of the 4 institutions was 136.671 million yuan.

Huasoft Technology: It fell to a halt today, with a turnover rate of 4.97% and a turnover of 169 million yuan, an amplification of 7.2%. According to Dragon Tiger Index data, the net purchase of the Shenzhen Stock Connect exclusive seat was 5.6972 million yuan, and the net purchase of the three institutions was 1.391 million yuan.

Yidao Information: Today's decline was 0.14%, the turnover rate was 22.72%, and the turnover was 276 million yuan, an increase of 12.40%. According to Dragon Tiger Index data, the net purchase of the Shenzhen Stock Connect exclusive seat was 4871,000 yuan, 2 institutions bought 10.7909 million yuan, and 3 institutions sold 245.924 million yuan.

Ed Biotech: Today's 20CM rose and stopped, with a turnover rate of 3.45% and a turnover of 253 million yuan, an amplification of 17.36%. According to Dragon Tiger Index data, the net sales of exclusive seats on Shenzhen Stock Connect were 99.35 million yuan, the net purchase of the 3 institutions was 21.8886 million yuan, and the net sales of the 3 institutions were 22.614 million yuan.

Optical Bank Technology: Today, 20CM rose and stopped, with a turnover rate of 8.73%, a turnover of 746 million yuan, an amplification of 21.41%. According to Dragon Tiger Index data, the net purchase of the Shenzhen Stock Connect exclusive seat was 67.8572 million yuan, 1 institution had a net purchase of 14.0683 million yuan, and 1 institution had a net sale of 19.4867 million yuan.

In the Dragon Tiger list, Cambridge Technology's Shanghai Stock Connect exclusive seat had the largest net sales, with a net sale of RMB 28.16 million.

In the Dragon Tiger list, Ed Biotech's Shenzhen Stock Connect exclusive seat had the largest net sales, with a net sale of 99.35 million yuan.

Trends in volatile capital operations:

Foshan Shadowfoot: Net purchase of Longjin Pharmaceutical for 364.553 million yuan

Pink kudzu: net purchase of Shenzhen China A for 31.35 million yuan

Shandong Bang: Net sale of Shenzhen China A to 21.41 million yuan

Hujialou: Net sales of 15.56 million yuan for Zhongji Health

Chen Xiaoqun: Net sales of Jiuding's investment of 28.13 million yuan

Ningbo Sangtian Road: net sale of Shanghai's Sanmao to 29.96 million yuan

Zushou Xinyi: Net sales of Sino-Malaysian Transmission for 39.33 million yuan

Fang Xinxia: Net sales of Jiuding's investment of 15.26 million yuan and Pudong Jinqiao of 27.26 million yuan